Your search returned 2 results.

Results
	1.	Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors: Waksman, Ron PMID: 26470647 Year: 2016 Citation: Lancet. 387(10013):31-9, 2016 Jan 2. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W DOI: http://dx.doi.org/10.1016/S0140-6736(15)00447-X Add to cart (remove)
	2.	Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. MedStar authors: Waksman, Ron Weissman, Neil J PMID: 23339805 Year: 2013 Citation: Eurointervention. 8(9):1006-11, 2013 Jan 22. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Deleanu D, Dorobantu M, Hamon M, Niculescu R, Waksman R, Weissman NJ DOI: http://dx.doi.org/10.4244/EIJV8I9A155 Add to cart (remove)

Refine your search